Editorial disclosure: We earn from qualifying Amazon purchases at no extra cost to you. Picks are independently researched. Full disclosure →

Supplement bottles, capsules, and powder on marble surface

THE SUPPLEMENT DESK·VOL. ASHWAGANDHA·2026

Ashwagandha Side Effects & Who Shouldn't Take It

Most adults tolerate it well. But specific groups should avoid it or check with their doctor first: hyperthyroid patients, autoimmune disease, pregnancy/breastfeeding, certain medications. The honest safety review with peer-reviewed sources.

· Independently researched
ByKevin Geary·Co-Founder & Research Lead
Updated May 28, 2026

The short answer: well-tolerated by most, but specific groups should avoid it

Quick answer

Most healthy adults tolerate ashwagandha well at standard doses (300-600mg/day of standardized extract). The most common side effects in published trials are mild and GI-related: drowsiness, mild stomach upset, and (less commonly) headache. The specific groups who should AVOID ashwagandha or check with their doctor first: (1) Hyperthyroid patients — multiple trials including Salve 2019 documented increases in T3 + T4 thyroid hormones, which is problematic if you're already hyperthyroid. (2) Autoimmune disease (Hashimoto's, lupus, MS, RA) — ashwagandha stimulates Th1 immune response, which can worsen Th1-dominant autoimmune conditions. (3) Pregnant or breastfeeding women — insufficient safety data, plus traditional use as an abortifacient warrants caution. (4) People on thyroid medication, diabetes medication, or sedatives — interactions documented. (5) Liver disease history — rare case reports of hepatotoxicity in LiverTox database.

Ashwagandha (Withania somnifera) is one of the most-researched adaptogens with reasonable evidence for stress + anxiety reduction. But it's not appropriate for everyone. The contraindication list isn't long, but the items on it are clinically important. If any apply to you, the cost-benefit calculation changes substantially.

The safety profile for healthy adults is generally favorable in the published trials. Lopresti 2019 and other randomized trials tracked side effects systematically and found rates similar to placebo at standard doses for healthy adult populations. The concerns are concentrated in specific subgroups.

The thyroid effect (important for hyperthyroid + Hashimoto's)

Quick answer

Yes, often measurably. Multiple controlled trials including Salve et al. 2019 (Cureus) and Sharma et al. 2018 (J Altern Complement Med) documented that ashwagandha supplementation increased serum T3 and T4 thyroid hormones in subjects with subclinical hypothyroidism over 8 weeks. This is a benefit for hypothyroid users but a potential problem for hyperthyroid users (where elevated thyroid hormones are the underlying issue). For Hashimoto's thyroiditis — an autoimmune hypothyroid condition — the picture is more complex: the thyroid-hormone-increasing effect could be helpful, but the immune-stimulation effect (Th1) could potentially worsen the autoimmune component. Most clinicians familiar with thyroid + adaptogens recommend caution for autoimmune thyroid conditions specifically.

The thyroid-modulating effect of ashwagandha is one of the most clinically relevant safety considerations. For someone with subclinical hypothyroidism, the small increase in T3 + T4 could be a benefit — fewer hypothyroid symptoms without prescription medication. For someone with hyperthyroidism (Graves' disease, toxic nodular goiter), the same increase could be harmful.

The Hashimoto's situation is the most nuanced. Hashimoto's is an autoimmune condition where the immune system attacks the thyroid, eventually producing hypothyroidism. Ashwagandha's thyroid-hormone-increasing effect could help with the hypothyroid symptoms, but its immune-stimulating effect could potentially worsen the autoimmune attack. The trial data on Hashimoto's specifically is limited, and most integrative practitioners recommend either avoiding ashwagandha in Hashimoto's or only using it under monitored guidance.

If you have any thyroid condition diagnosed or suspected, do not start ashwagandha without discussing with your endocrinologist. The interaction is meaningful enough that a thyroid panel before + 8 weeks after starting is the reasonable monitoring approach.

The autoimmune concern

Quick answer

Generally no — or only under medical guidance. Ashwagandha contains withanolides that stimulate the Th1 branch of the immune system (cellular immunity). This is helpful for general immune function, but it can theoretically worsen Th1-dominant autoimmune conditions including Hashimoto's, lupus, multiple sclerosis, rheumatoid arthritis, type 1 diabetes, and inflammatory bowel disease. The published trials in autoimmune conditions specifically are limited, and the case-report literature has occasional reports of autoimmune flares attributed to adaptogen use. The conservative approach: if you have an autoimmune diagnosis, talk to your rheumatologist or treating specialist before starting ashwagandha. If they're unfamiliar with the immunomodulation literature, ask them to consult a functional medicine physician or integrative practitioner familiar with adaptogens.

The autoimmune contraindication is theoretical-mechanistic rather than RCT-proven, but it's the standard precaution in integrative medicine. The Th1 vs Th2 balance is one of the underlying drivers of autoimmune disease, and supplements that shift the balance in either direction can affect disease activity.

The published evidence base specifically in autoimmune populations is small. Most RCTs of ashwagandha enroll healthy adults or specific symptom populations (anxiety, stress, sleep) and exclude major autoimmune disease. This means we have less direct evidence about ashwagandha's effects on autoimmune disease activity, which itself is a reason for caution.

For patients with autoimmune conditions seeking adaptogen-style stress support, the alternatives with less Th1-stimulating profile include Rhodiola, holy basil (tulsi), and L-theanine. None has the breadth of ashwagandha's evidence base for anxiety, but the autoimmune-stimulating concern is reduced.

Medication interactions

Quick answer

Yes — several interactions are documented. (1) Thyroid medications (levothyroxine, Synthroid) — ashwagandha's thyroid hormone-increasing effect can compound with prescription thyroid replacement, potentially causing hyperthyroid symptoms. (2) Diabetes medications — ashwagandha may modestly lower blood glucose, additive with diabetes drugs and insulin. (3) Sedatives + sleeping medications (benzodiazepines, Z-drugs, opioids) — ashwagandha has GABAergic effects that can compound sedation. (4) Immunosuppressants (cyclosporine, tacrolimus, biologics for autoimmune disease) — the immune-stimulating effect can theoretically reduce immunosuppressant efficacy. (5) Blood pressure medications — ashwagandha may have mild hypotensive effect, additive with BP medications. If you take prescription medication in any of these categories, ask your prescriber before adding ashwagandha.

The medication interactions aren't exotic — they follow logically from ashwagandha's known mechanisms. Thyroid-modulating, hypoglycemic, sedative, immune-stimulating, mildly hypotensive effects each map to a class of prescription drugs where additive effects could be problematic.

The practical mitigation isn't necessarily avoidance — it's informed dose adjustment. If you take levothyroxine and want to add ashwagandha, your endocrinologist can monitor TSH + Free T4 and reduce your levothyroxine dose if appropriate. Same logic for diabetes meds: if ashwagandha helps with insulin sensitivity, your prescriber may need to adjust your diabetes medication downward to avoid hypoglycemia.

The conservative posture for anyone on prescription medication is: don't add ashwagandha without your prescriber knowing about it. The supplement isn't the problem; uncoordinated additive effects with your prescription medications might be.

Other cautions: pregnancy, liver, and dose

Quick answer

No — pregnancy is a clear contraindication. Ashwagandha has been used in traditional Ayurvedic medicine as an abortifacient, and the published modern safety data is insufficient to recommend supplementation during pregnancy. Breastfeeding safety is also poorly characterized; the conservative approach is to avoid during lactation. Liver safety is also worth knowing: the NIH LiverTox database includes occasional case reports of ashwagandha-associated hepatotoxicity, with most cases resolving after discontinuation. Most case reports involve high doses or combination products. People with pre-existing liver disease should avoid or only use under hepatology guidance. Standard doses (300-600mg/day) for short-medium term use in healthy adults appear safe based on the published RCT data.

The pregnancy contraindication is the firmest in the safety profile. Traditional use as an abortifacient means there's historical evidence that high doses can affect pregnancy outcomes, and the modern safety evaluation simply doesn't exist at adequate scale to override that concern. Don't take ashwagandha if pregnant, planning to become pregnant, or breastfeeding.

The liver concern is rare but worth knowing about. The LiverTox database tracks adverse hepatic events from supplements and medications, and ashwagandha has accumulated enough case reports to warrant inclusion. Most cases resolve after stopping the supplement, but a few have required medical intervention. The signal is small relative to the millions of people who take ashwagandha without issue, but it's real.

For dose, the published RCTs use 300-600mg/day of standardized extract (typically KSM-66 or Sensoril). Higher doses don't appear to provide additional benefit but may increase side effect risk. Stick to the studied range unless you're working with a clinician.

Share:
GP

GiftedPicks Editorial Team

Product Research & Editorial

The GiftedPicks editorial team researches thousands of Amazon products, analyzes customer review patterns, cross-references clinical studies and community recommendations, and writes original editorial content for every list. We never accept payment from brands for placement or ranking.

Fact-checked May 2026Sources citedNo paid placements